AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cells.
Steroid hormones, including glucocorticoids and androgens, have potent actions to regulate many cellular processes within the liver. The steroid A-ring reductase, 5β-reductase (AKR1D1), is predominantly expressed in the liver, where it inactivates steroid hormones and, in addition, plays a crucial r...
Main Authors: | Nikolaou, N, Gathercole, L, Kirkwood, L, Dunford, J, Hughes, B, Gilligan, L, Oppermann, U, Penning, T, Arlt, W, Hodson, L, Tomlinson, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2019
|
Similar Items
-
Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivo
by: Nikolaou, N, et al.
Published: (2020) -
Human and murine steroid 5β-reductases (AKR1D1 and AKR1D4): Insights into the role of the catalytic glutamic acid
by: Chen, M, et al.
Published: (2019) -
AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease.
by: Nikolaou, N, et al.
Published: (2019) -
Glucocorticoid modulation of insulin signaling in human subcutaneous adipose tissue.
by: Gathercole, L, et al.
Published: (2007) -
Glucocorticoid and Insulin Regulation of Lipogenesis in Human Adipose Tissue.
by: Gathercole, L, et al.
Published: (2010)